Routine mid-gestational prediction of later preeclampsia

Area of Science:

• Obstetrics and Gynecology
• Cardiovascular Health
• Metabolic Disorders

Background:

• Preeclampsia often develops in women with pre-existing cardiovascular and cardiometabolic risk factors, resembling metabolic syndrome.
• Early identification of preeclampsia risk is crucial for timely intervention and improved maternal and fetal outcomes.

Purpose of the Study:

• To develop and validate a prediction model for preeclampsia using data from routine second-trimester oral glucose tolerance testing.
• To identify key clinical predictors for preeclampsia development in pregnant women.

Main Methods:

• Prospective clinical cohort study involving 3227 pregnant women undergoing gestational diabetes mellitus screening.
• Logistic regression and backward Wald elimination were used to develop the prediction model.
• Internal validation was performed using bootstrapping, with performance evaluated by discrimination and calibration.

Main Results:

• The final model included obstetric history of preeclampsia, history of large for gestational age, antihypertensive drug use, diastolic blood pressure, fasting serum creatinine, fasting serum triglycerides, and urinary protein-creatinine ratio.
• The model achieved an area under the receiver operating characteristic curve of 0.79, demonstrating good predictive performance and calibration.
• External validation confirmed the model's ability to accurately estimate preeclampsia risk, predominantly for third-trimester development.

Conclusions:

• A validated second-trimester prediction model can accurately identify pregnant women at risk for developing preeclampsia.
• This model facilitates tailored monitoring and early intervention strategies for high-risk pregnancies.
• Implementing this prediction model has the potential to improve pregnancy outcomes by enabling proactive management.